153 related articles for article (PubMed ID: 30337050)
1. [Radiation-induced lung toxicity predictors after stereotactic radiation therapy for non-small cell lung carcinoma stage I].
Menoux I; Le Fèvre C; Noël G; Antoni D
Cancer Radiother; 2018 Dec; 22(8):826-838. PubMed ID: 30337050
[TBL] [Abstract][Full Text] [Related]
2. Radiation-induced lung toxicity predictors: Retrospective analysis of 90 patients treated with stereotactic body radiation therapy for stage I non-small-cell lung carcinoma.
Menoux I; Antoni D; Mazzara C; Labani A; Charloux A; Quoix E; Falcoz PE; Truntzer P; Noël G
Cancer Radiother; 2020 Apr; 24(2):120-127. PubMed ID: 32173269
[TBL] [Abstract][Full Text] [Related]
3. [Radiological evaluation of the tumour response after lung stereotactic radiotherapy].
Vulquin N; Feutray S; Peignaux-Casasnovas K; Humbert O; Créhange G; Truc G; Maingon P; Martin E
Cancer Radiother; 2014 Oct; 18(5-6):414-9. PubMed ID: 25199864
[TBL] [Abstract][Full Text] [Related]
4. Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
Kong FS; Moiseenko V; Zhao J; Milano MT; Li L; Rimner A; Das S; Li XA; Miften M; Liao Z; Martel M; Bentzen SM; Jackson A; Grimm J; Marks LB; Yorke E
Int J Radiat Oncol Biol Phys; 2021 May; 110(1):172-187. PubMed ID: 30496880
[TBL] [Abstract][Full Text] [Related]
5. Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 Studies.
Zhao J; Yorke ED; Li L; Kavanagh BD; Li XA; Das S; Miften M; Rimner A; Campbell J; Xue J; Jackson A; Grimm J; Milano MT; Spring Kong FM
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1357-1366. PubMed ID: 27325482
[TBL] [Abstract][Full Text] [Related]
6. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of whether radiation pneumonitis is influenced by low-dose irradiated lung volume in primary lung cancer with chronic pulmonary disease.
Niibe Y; Hayakawa K; Masuda N; Yoshimura H
Gan To Kagaku Ryoho; 2007 Feb; 34(2):213-6. PubMed ID: 17301529
[TBL] [Abstract][Full Text] [Related]
8. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
[TBL] [Abstract][Full Text] [Related]
9. [Limits of dose constraint definition for organs at risk specific to stereotactic radiotherapy].
Beddok A; Loi M; Rivin Del Campo E; Dumas JL; Orthuon A; Créhange G; Huguet F
Cancer Radiother; 2023 Jun; 27(4):341-348. PubMed ID: 37208260
[TBL] [Abstract][Full Text] [Related]
10. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors.
Roach M; Gandara DR; Yuo HS; Swift PS; Kroll S; Shrieve DC; Wara WM; Margolis L; Phillips TL
J Clin Oncol; 1995 Oct; 13(10):2606-12. PubMed ID: 7595714
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiation therapy for stage I non-small cell lung carcinomas: Moderate hypofractionation optimizes outcome.
Menoux I; Antoni D; Truntzer P; Keller A; Massard G; Noël G
Lung Cancer; 2018 Dec; 126():201-207. PubMed ID: 30527188
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors Associated With Symptomatic Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
Shi S; Zeng Z; Ye L; Huang Y; He J
Technol Cancer Res Treat; 2017 Jun; 16(3):316-320. PubMed ID: 27516466
[TBL] [Abstract][Full Text] [Related]
13. [Radiotherapy of Lung Tumours in Idiopathic Pulmonary Fibrosis].
Kolek V; Vašáková M; Šterclová M; Cwiertka K; Vrána D; Kudláček A; Skřičková J; Pešek M; Petera J
Klin Onkol; 2017; 30(4):303-306. PubMed ID: 28832178
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric factors predicting radiation pneumonitis after CyberKnife stereotactic body radiotherapy for peripheral lung cancer.
Nakamura M; Nishimura H; Nakayama M; Mayahara H; Uezono H; Harada A; Hashimoto N; Ejima Y; Ishihara T; Sasaki R
Br J Radiol; 2016 Dec; 89(1068):20160560. PubMed ID: 27805837
[TBL] [Abstract][Full Text] [Related]
15. Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.
Onishi H; Marino K; Yamashita H; Terahara A; Onimaru R; Kokubo M; Shioyama Y; Kozuka T; Matsuo Y; Aruga T; Hiraoka M
Technol Cancer Res Treat; 2018 Jan; 17():1533033818801323. PubMed ID: 30286697
[TBL] [Abstract][Full Text] [Related]
16. Inhalative steroids as an individual treatment in symptomatic lung cancer patients with radiation pneumonitis grade II after radiotherapy - a single-centre experience.
Henkenberens C; Janssen S; Lavae-Mokhtari M; Leni K; Meyer A; Christiansen H; Bremer M; Dickgreber N
Radiat Oncol; 2016 Feb; 11():12. PubMed ID: 26830686
[TBL] [Abstract][Full Text] [Related]
17. Radiation pneumonitis and pulmonary fibrosis in non-small-cell lung cancer: pulmonary function, prediction, and prevention.
Mehta V
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):5-24. PubMed ID: 15963660
[TBL] [Abstract][Full Text] [Related]
18. Evaluating Which Dose-Function Metrics Are Most Critical for Functional-Guided Radiation Therapy.
Faught AM; Yamamoto T; Castillo R; Castillo E; Zhang J; Miften M; Vinogradskiy Y
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):202-209. PubMed ID: 28816147
[TBL] [Abstract][Full Text] [Related]
19. Unusual tumor response and toxicity from radiation and concurrent erlotinib for non-small-cell lung cancer.
Nanda A; Dias-Santagata DC; Stubbs H; O'Hara CJ; Zaner KS; Lynch TJ; Willers H
Clin Lung Cancer; 2008 Sep; 9(5):285-7. PubMed ID: 18824451
[TBL] [Abstract][Full Text] [Related]
20. Radiological assessment after stereotactic body radiation of lung tumours.
Chassagnon G; Martini K; Giraud P; Revel MP
Cancer Radiother; 2020 Aug; 24(5):379-387. PubMed ID: 32534799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
